Close Menu

23andMe is once again providing its customers with health-related data, the New York Times reports. It notes, though, that the data is not as wide-ranging as it had previously been.

Nearly two years ago, the US Food and Drug Administration sent 23andMe a letter telling it to cease marketing its health test as the agency had concerns regarding its validity.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.